No Data
Both Individual Investors Who Control a Good Portion of Inner Mongolia Furui Medical Science Co., Ltd. (SZSE:300049) Along With Institutions Must Be Dismayed After Last Week's 4.9% Decrease
Inner Mongolia Furui Medical Science (300049.SZ): Currently, there is sufficient production capacity for Fibroscan in France.
Gelonghui reported on March 4 that Inner Mongolia Furui Medical Science (300049.SZ) stated on the investor interaction platform that there is currently sufficient capacity for Fibroscan in France.
Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the
① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.
Inner Mongolia Furui Medical Science (300049.SZ): Currently, the company has not yet connected to the DeepSeek system.
On February 19, Gelonghui reported that Inner Mongolia Furui Medical Science (300049.SZ) stated on the investor interaction platform that the company has not yet integrated the DeepSeek system. The company is actively monitoring the development of cutting-edge technologies in the innovative Medical Device field and will prudently evaluate the applicability of related technologies in the company's Operation and Business development based on actual needs and technical applicability, further strengthening digital and Asia Vets applications.
Inner Mongolia Furui Medical Science Co., Ltd.'s (SZSE:300049) P/E Still Appears To Be Reasonable
Furui Co., Ltd.: 2024 performance forecast
After Leaping 37% Inner Mongolia Furui Medical Science Co., Ltd. (SZSE:300049) Shares Are Not Flying Under The Radar
